Trials / Unknown
UnknownNCT04437056
Nerve Transfers in Post-stroke Spasticity
Outcome Measurements After Cognitive Nerve Transfers to Spastic Muscles in Stroke Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Stroke is nowadays a leading cause of disability with devastating sequelae. Upper limb spasticity is one of them. Nevertheless, not all the muscles are equally affected, as some may turn spastic or paretic and other remain intact. This unique pathophysiological mosaic dictates a precise therapeutic plan. Existing spasticity treatment has significant drawbacks due to its unspecific targeting and short duration. A causal, life-lasting treatment, precisely adapted to every single patient's needs and to disease pattern, is currently missing. Hyperselective muscle denervation and subsequent cognitive reinnervation with appropriate unaffected donor nerves may break the pathological spastic circuit and provide volitional muscle control. With this pioneering study we will perform cognitive nerve transfers to spastic muscles and will prospectively investigate their effects on clinical, electrophysiological, molecular-biological and histological level. Accurate donor nerve selection will be for the first time quantified through motor unit number estimation with high-density needle electromyography. This revolutionary concept can open the window to a new era of therapeutic possibilities for stroke victims.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cognitive nerve transfers to spastic upper extremity muscles in stroke patients | Based on the fact that upper motor neuron syndrome after stroke is presented with variable clinical features, usually without affecting in the same way the entire upper extremity, we aim to investigate the efficacy of nerve transfers to spastic muscles after stroke using as donor nerves that innervate unaffected ipsilateral volitionally controlled muscles. |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2023-12-31
- Completion
- 2025-12-31
- First posted
- 2020-06-18
- Last updated
- 2022-04-12
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04437056. Inclusion in this directory is not an endorsement.